Citius Pharmaceuticals IncNASDAQ:CTXR
- LAST PRICE1.3200
- TODAY'S CHANGE (%)0.0800 (6.4516%)
- Bid / Lots1.2800/ 9
- Ask / Lots1.3200/ 43
- Open / Previous Close1.2500 / 1.2400
- Day Range
- 52 Week Range
- Volume1,624,541
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CTXR |
|---|---|---|
| 09:32 ET | 17171 | 1.25 |
| 09:34 ET | 1210 | 1.255 |
| 09:36 ET | 15045 | 1.255 |
| 09:38 ET | 9299 | 1.255 |
| 09:39 ET | 22540 | 1.265 |
| 09:41 ET | 6804 | 1.255 |
| 09:43 ET | 10770 | 1.2583 |
| 09:45 ET | 10800 | 1.265 |
| 09:48 ET | 5270 | 1.255 |
| 09:50 ET | 10200 | 1.255 |
| 09:52 ET | 5469 | 1.2594 |
| 09:54 ET | 63215 | 1.24 |
| 09:56 ET | 5905 | 1.2447 |
| 09:57 ET | 3570 | 1.245 |
| 09:59 ET | 600 | 1.2487 |
| 10:01 ET | 9754 | 1.235 |
| 10:03 ET | 32328 | 1.235 |
| 10:06 ET | 2020 | 1.24 |
| 10:08 ET | 1637 | 1.24 |
| 10:10 ET | 100 | 1.235 |
| 10:12 ET | 900 | 1.235 |
| 10:14 ET | 2300 | 1.235 |
| 10:15 ET | 1450 | 1.235 |
| 10:17 ET | 1634 | 1.235 |
| 10:19 ET | 500 | 1.2332 |
| 10:21 ET | 100 | 1.235 |
| 10:24 ET | 520 | 1.235 |
| 10:26 ET | 500 | 1.23 |
| 10:28 ET | 200 | 1.23 |
| 10:30 ET | 16745 | 1.2301 |
| 10:32 ET | 5600 | 1.24 |
| 10:33 ET | 72627 | 1.25 |
| 10:35 ET | 800 | 1.245 |
| 10:37 ET | 35041 | 1.2499 |
| 10:39 ET | 1400 | 1.245 |
| 10:42 ET | 500 | 1.245 |
| 10:44 ET | 1215 | 1.245 |
| 10:46 ET | 2399 | 1.24 |
| 10:48 ET | 4144 | 1.245 |
| 10:50 ET | 400 | 1.25 |
| 10:53 ET | 300 | 1.245 |
| 10:57 ET | 800 | 1.245 |
| 11:00 ET | 550 | 1.2432 |
| 11:02 ET | 511 | 1.245 |
| 11:04 ET | 5319 | 1.2461 |
| 11:06 ET | 1400 | 1.25 |
| 11:08 ET | 11645 | 1.245 |
| 11:09 ET | 1504 | 1.245 |
| 11:11 ET | 1100 | 1.245 |
| 11:13 ET | 300 | 1.245 |
| 11:15 ET | 400 | 1.245 |
| 11:18 ET | 1000 | 1.245 |
| 11:20 ET | 4800 | 1.245 |
| 11:22 ET | 977 | 1.25 |
| 11:24 ET | 9865 | 1.26 |
| 11:26 ET | 300 | 1.265 |
| 11:27 ET | 601 | 1.265 |
| 11:29 ET | 4530 | 1.255 |
| 11:31 ET | 1650 | 1.25 |
| 11:33 ET | 1000 | 1.25 |
| 11:36 ET | 1686 | 1.25 |
| 11:38 ET | 900 | 1.245 |
| 11:40 ET | 1900 | 1.25 |
| 11:42 ET | 800 | 1.26 |
| 11:44 ET | 4113 | 1.245 |
| 11:45 ET | 2941 | 1.255 |
| 11:47 ET | 46289 | 1.25 |
| 11:49 ET | 23954 | 1.265 |
| 11:51 ET | 3000 | 1.265 |
| 11:54 ET | 1426 | 1.265 |
| 11:56 ET | 900 | 1.2691 |
| 11:58 ET | 1490 | 1.265 |
| 12:00 ET | 1297 | 1.265 |
| 12:02 ET | 1970 | 1.265 |
| 12:03 ET | 1200 | 1.265 |
| 12:05 ET | 1000 | 1.265 |
| 12:07 ET | 700 | 1.265 |
| 12:09 ET | 800 | 1.26 |
| 12:12 ET | 1400 | 1.265 |
| 12:14 ET | 4315 | 1.265 |
| 12:16 ET | 1253 | 1.265 |
| 12:18 ET | 4200 | 1.265 |
| 12:20 ET | 200 | 1.27 |
| 12:21 ET | 1685 | 1.265 |
| 12:23 ET | 400 | 1.265 |
| 12:25 ET | 22155 | 1.25 |
| 12:27 ET | 420 | 1.255 |
| 12:30 ET | 360 | 1.255 |
| 12:32 ET | 5100 | 1.2501 |
| 12:36 ET | 4286 | 1.25 |
| 12:38 ET | 2786 | 1.245 |
| 12:39 ET | 1438 | 1.245 |
| 12:41 ET | 700 | 1.245 |
| 12:43 ET | 300 | 1.245 |
| 12:45 ET | 400 | 1.245 |
| 12:48 ET | 200 | 1.245 |
| 12:50 ET | 2749 | 1.245 |
| 12:52 ET | 5453 | 1.255 |
| 12:54 ET | 200 | 1.255 |
| 12:56 ET | 400 | 1.255 |
| 12:57 ET | 4721 | 1.245 |
| 12:59 ET | 1404 | 1.245 |
| 01:01 ET | 500 | 1.245 |
| 01:06 ET | 100 | 1.245 |
| 01:08 ET | 296 | 1.245 |
| 01:10 ET | 2100 | 1.245 |
| 01:12 ET | 10400 | 1.2401 |
| 01:14 ET | 1100 | 1.245 |
| 01:15 ET | 19714 | 1.235 |
| 01:17 ET | 5382 | 1.2419 |
| 01:19 ET | 200 | 1.24 |
| 01:21 ET | 26800 | 1.245 |
| 01:24 ET | 2300 | 1.2406 |
| 01:26 ET | 100 | 1.245 |
| 01:28 ET | 380 | 1.2499 |
| 01:30 ET | 1275 | 1.2409 |
| 01:32 ET | 569 | 1.245 |
| 01:35 ET | 100 | 1.245 |
| 01:39 ET | 1000 | 1.2459 |
| 01:42 ET | 700 | 1.245 |
| 01:44 ET | 5818 | 1.25 |
| 01:46 ET | 1271 | 1.25 |
| 01:48 ET | 823 | 1.245 |
| 01:50 ET | 704 | 1.25 |
| 01:51 ET | 1001 | 1.25 |
| 01:53 ET | 300 | 1.25 |
| 01:55 ET | 1267 | 1.245 |
| 01:57 ET | 1247 | 1.245 |
| 02:00 ET | 2300 | 1.245 |
| 02:02 ET | 7200 | 1.2401 |
| 02:04 ET | 200 | 1.245 |
| 02:08 ET | 31409 | 1.245 |
| 02:09 ET | 200 | 1.245 |
| 02:11 ET | 1172 | 1.24 |
| 02:13 ET | 340 | 1.245 |
| 02:15 ET | 7868 | 1.245 |
| 02:18 ET | 1869 | 1.25 |
| 02:20 ET | 1917 | 1.245 |
| 02:22 ET | 700 | 1.245 |
| 02:24 ET | 31418 | 1.255 |
| 02:26 ET | 6434 | 1.255 |
| 02:27 ET | 5852 | 1.265 |
| 02:29 ET | 700 | 1.265 |
| 02:31 ET | 1344 | 1.265 |
| 02:33 ET | 11600 | 1.265 |
| 02:36 ET | 500 | 1.265 |
| 02:38 ET | 800 | 1.265 |
| 02:40 ET | 100 | 1.27 |
| 02:42 ET | 1632 | 1.265 |
| 02:44 ET | 570 | 1.26 |
| 02:45 ET | 100 | 1.265 |
| 02:47 ET | 13810 | 1.255 |
| 02:49 ET | 1637 | 1.26 |
| 02:51 ET | 1613 | 1.26 |
| 02:54 ET | 794 | 1.255 |
| 02:56 ET | 2781 | 1.255 |
| 02:58 ET | 500 | 1.255 |
| 03:00 ET | 100 | 1.255 |
| 03:02 ET | 1421 | 1.255 |
| 03:05 ET | 2305 | 1.26 |
| 03:07 ET | 1900 | 1.26 |
| 03:09 ET | 2071 | 1.26 |
| 03:12 ET | 1610 | 1.255 |
| 03:14 ET | 500 | 1.26 |
| 03:16 ET | 200 | 1.26 |
| 03:18 ET | 740 | 1.2599 |
| 03:20 ET | 2850 | 1.26 |
| 03:21 ET | 4770 | 1.265 |
| 03:23 ET | 19947 | 1.255 |
| 03:25 ET | 3600 | 1.2505 |
| 03:27 ET | 1000 | 1.255 |
| 03:30 ET | 1604 | 1.251 |
| 03:32 ET | 3399 | 1.255 |
| 03:34 ET | 40352 | 1.265 |
| 03:36 ET | 5221 | 1.265 |
| 03:38 ET | 1887 | 1.27 |
| 03:39 ET | 4807 | 1.27 |
| 03:41 ET | 18302 | 1.26 |
| 03:43 ET | 5536 | 1.255 |
| 03:45 ET | 2520 | 1.255 |
| 03:48 ET | 3898 | 1.255 |
| 03:50 ET | 11100 | 1.255 |
| 03:52 ET | 60837 | 1.27 |
| 03:54 ET | 79349 | 1.285 |
| 03:56 ET | 150505 | 1.3 |
| 03:57 ET | 127423 | 1.305 |
| 03:59 ET | 134081 | 1.32 |
May 12, 2023
BRIEF-Citius Pharmaceuticals Inc. Reports Fiscal Second Quarter 2023 Financial Results , from 4:38PM ET on Friday May 12, 2023 by Thomson Reuters
4:38PM ET on Friday May 12, 2023 by Thomson ReutersCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2023 Financial Results and Provides Business Update, from 4:30PM ET on Friday May 12, 2023 by PR Newswire
4:30PM ET on Friday May 12, 2023 by PR Newswire
May 8, 2023
Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering, from 1:42PM ET on Monday May 08, 2023 by PR Newswire
1:42PM ET on Monday May 08, 2023 by PR Newswire
May 4, 2023
Citius Pharmaceuticals Announces $15 Million Registered Direct Offering, from 8:00AM ET on Thursday May 04, 2023 by PR Newswire
8:00AM ET on Thursday May 04, 2023 by PR Newswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Citius Pharmaceuticals Inc | 209.7M | -6.2x | --- |
Altimmune Inc | 210.0M | -2.4x | --- |
Acumen Pharmaceuticals Inc | 212.1M | -4.7x | --- |
Kezar Life Sciences Inc | 207.1M | -2.7x | --- |
BioVie Inc | 219.9M | -3.7x | --- |
Rani Therapeutics Holdings Inc | 221.7M | -3.4x | --- |
Company Information
Citius Pharmaceuticals Inc. is a pharmaceutical company. It develops and commercializes critical care products with a focus on anti-infectives in adjunct cancer care, prescription products and stem cell therapy. Its products include Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. I/ONTAK is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Its Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. Its Halo-Lido is a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Wrap is a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries. Its NoveCite is a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome (ARDS).
Contact Information
- Headquarters
- 11 Commerce Dr Fl 1CRANFORD, NJ, United States 07016-3501
- Phone
- 908-967-6677
- Fax
- ---
Executives
- Executive Chairman of the Board, Chief Executive Officer, Company Secretary
- Leonard Mazur
- Executive Vice Chairman of the Board
- Myron Holubiak
- Chief Financial Officer, Chief Business Officer
- Jaime Bartushak
- Chief Medical Officer, Executive Vice President
- Myron Czuczman
- Vice President - Corporate Communications and Investor Relations
- Ilanit Allen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $209.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 158.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.39 |
EPS | $-0.21 |
Book Value | $0.70 |
P/E Ratio | -6.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
